Home Newsfeeds Value Line Q1 EPS $0.47 Down From $0.62 YoY

Value Line Q1 EPS $0.47 Down From $0.62 YoY

Value Line (NASDAQ:VALU) reported quarterly earnings of $0.47 per share. This is a 24.19 percent decrease over earnings of $0.62 per share from the same period last year.

byBenzinga Newsdesk

September 14, 2022

1 minute read

Value Line (NASDAQ:VALU) reported quarterly earnings of $0.47 per share. This is a 24.19 percent decrease over earnings of $0.62 per share from the same period last year.

Bitcoin’s Bullish Momentum Faces Threat Of Bearish Divergence

By Rounak Jain

November 25, 4:55 AM

The price of Bitcoin (CRYPTO: BTC) could potentially drop to $30,000 due to a looming bearish divergence, even as bulls are steaming ahead to th

BTC

Artelo Biosciences Announces Publication Of New Peer-Reviewed Research Demonstrating Protective Properties Of ART27.13 Against Muscle Degeneration Caused By Certain Cancers

By Benzinga Newsdesk

November 9, 10:23 AM

Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological

ARTL

News

NYSE American Initiates Delisting Proceedings For BiomX Warrants

By Happy Mohamed

June 8, 5:02 PM

BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the

PHGE

Why Pet Food Company Freshpet’s Shares Are Jumping Today

By Shivani Kumaresan

May 6, 8:50 AM

Freshpet Inc surges on solid Q1 FY24 earnings, beating sales estimates with a 33.6% YoY growth to $223.85 million. Gross profit skyrockets by 73.6%, reaching $88.2 million, as margins expand to 39.4%. Improved efficiency and lower input costs drive profitability, while adjusted EBITDA soars to $30.6 million.

FRPT

Value Line Q1 EPS $0.47 Down From $0.62 YoY

Related Posts

Bitcoin’s Bullish Momentum Faces Threat Of Bearish Divergence

Artelo Biosciences Announces Publication Of New Peer-Reviewed Research Demonstrating Protective Properties Of ART27.13 Against Muscle Degeneration Caused By Certain Cancers

NYSE American Initiates Delisting Proceedings For BiomX Warrants

Why Pet Food Company Freshpet’s Shares Are Jumping Today